Weekender 1/29/16

As we prepare to honor New Jersey’s Innovators that received drug approvals in 2015 at our upcoming Annual Dinner Meeting on February 4, the Garden State is off to a strong start again in 2016 with drug approvals over the last week going to BioNJ Members Genmab, Eli Lilly, Merck, Allergan and Bristol-Myers Squibb. Congrats! Meanwhile, a… Read the full article


Weekender 1/22/16

With 2016 in full swing, New Jersey’s vibrant life sciences ecosystem continues to do what it does best — bring new cures and therapies to the Patients who need them.    Congratulations to BioNJ Member Novartis Pharmaceuticals for receiving two new FDA approvals for Cosentyx to treat patients with Ankylosing Spondylitis and Psoriatic Arthritis. This is in addition… Read the full article


Weekender 1/8/16

With nearly 60% of all of last year’s FDA new drug approvals coming from companies with a footprint in New Jersey, the Garden State’s robust life sciences community has once again played a prominent role in delivering novel life-changing therapies and cures to Patients around the world. We look forward to even more innovation in the… Read the full article


Weekender 12/18/15

More promise for Patients as a result of the innovation coming out of New Jersey’s life sciences ecosystem… Breaking News: BioNJ President and CEO Debbie Hart was named to a list of 38 “Women of Power” in the most recent issue of HudsonMOD along with Diane Von Furstenberg, Ivanka Trump, Sandra E. Peterson, Sheri McCoy,… Read the full article


Weekender 12/11/15

This week’s Weekender is a celebration of collaboration on medical innovation and the approval of additional drugs for the Patients who need them… Congratulations to BioNJ Member Rutgers Cancer Institute of New Jersey on their recent grant from the American Cancer Society! An additional congratulations goes to BioNJ Members Bristol-Myers Squibb and Princeton University Department… Read the full article


Weekender 12/4/15

This week’s edition of the Weekender is about new drug approvals, New Jersey’s role in the launch of the Congressional Life Science Caucus, important partnerships forging medical innovation and New Jersey’s fastest growing companies… Congressman Leonard Lance recently announced the creation of the Congressional Life Science Caucus that will serve as a bipartisan working group…. Read the full article


Weekender 11/20/15

New Jersey is at the top of the list for biotech growth potential, Camden ‘Eds and Meds’ have a $2 billion impact, Chugai opens new US facility in the Garden State, new FDA drug and medical device approvals and more. New Jersey’s innovative life sciences ecosystem keeps it coming… New Jersey’s dominance in biotechnology was… Read the full article


Weekender 11/13/15

This week’s Weekender focuses on the promise of continued innovation… BioNJ applauds Governor Chris Christie who approved biosimilars legislation on Tuesday. As a result of the signing of this bill, New Jersey patients will now have access to these life-saving medications while knowing that their safety is protected. Because biosimilars can never be exact replicates… Read the full article


Weekender 11/6/15

Welcome to this week’s edition of the Weekender. New Jersey’s life sciences community continues to provide inspiration, innovation and hope for Patients around the world… We start this week’s Weekender off with a special call out to precious 6-year old Patient Advocate Max Schill, who won the Abbey Award for Federal Level Advocacy at the… Read the full article


Weekender 10/30/15

Welcome to this week’s edition of the Weekender. Congratulations to our New Jersey life sciences companies that continue to make an important impact on the industry delivering innovative therapies and drugs to the Patients who need… BioNJ Member OrthogenRx announced FDA approval of GenVisc 850®, indicated for the treatment of pain in osteoarthritis (OA) of… Read the full article